2013
DOI: 10.3109/1354750x.2013.840799
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin-6 polymorphisms and hematologic malignancy: a re-appraisal of evidence from genetic association studies

Abstract: There is accumulating evidence that the IL-6 promoter, receptor and signal transducer SNPs can modify disease susceptibility.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0
2

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 50 publications
0
7
0
2
Order By: Relevance
“…35 Notably, the aggravating role of P15INK4b promoter methylation seemed rather universal, as it implicated both whites and Asians, whereas the effects of P16INK4a promoter methylation seemed confined to Asians. 35 Regarding inflammation-related molecules, a compendium of IL-6-related polymorphisms were associated with modified MM risk (rs6684439, rs2229238, rs8192284 polymorphisms in the IL-6 receptor and rs11744523 in the IL-6 signal transducer gp130), 39 in line with IL-6 as a growth factor for MM cells 79 and with the abnormally elevated serum IL-6 levels in MM patients, which may also correlate with prognosis 70,80 ; on the other hand, TNF promoter polymorphisms were not considerably associated with MM risk. 43 Finally, MTHFR C677T status seemed to modify MM risk, highlighting the role of the latter in DNA synthesis and methylation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…35 Notably, the aggravating role of P15INK4b promoter methylation seemed rather universal, as it implicated both whites and Asians, whereas the effects of P16INK4a promoter methylation seemed confined to Asians. 35 Regarding inflammation-related molecules, a compendium of IL-6-related polymorphisms were associated with modified MM risk (rs6684439, rs2229238, rs8192284 polymorphisms in the IL-6 receptor and rs11744523 in the IL-6 signal transducer gp130), 39 in line with IL-6 as a growth factor for MM cells 79 and with the abnormally elevated serum IL-6 levels in MM patients, which may also correlate with prognosis 70,80 ; on the other hand, TNF promoter polymorphisms were not considerably associated with MM risk. 43 Finally, MTHFR C677T status seemed to modify MM risk, highlighting the role of the latter in DNA synthesis and methylation.…”
Section: Discussionmentioning
confidence: 99%
“…35 Regarding inflammation-related molecules, a series of interleukin (IL)-6erelated polymorphisms were associated with modified MM risk (rs6684439, rs2229238, rs8192284 polymorphisms in the IL-6 receptor and rs11744523 in the IL-6 signal transducer gp130), 39 but tumor necrosis factor (TNF) promoter polymorphisms did not display significant associations. 43 Finally, regarding MTHFR, C677T status seemed to modify MM risk, whereas no associations implicated A1298C polymorphism.…”
Section: Wang 2014 35mentioning
confidence: 99%
“…The overproduction of hIL-6 and other proinflammatory cytokines is associated with severe chronic immune-mediated inflammatory diseases (IMIDs) such as rheumatoid arthritis [87] and atherosclerosis [88]. The disruption of hIL-6 expression also occurs during the neurodegenerative process in Alzheimer's disease [89] and high levels of this molecule are associated with several hyperproliferative diseases and with the progression of cancer [90, 91]. …”
Section: Human Interleukin-6mentioning
confidence: 99%
“…Recently, Sultana et al, (2018) (48) indicate that the C allele of IL-1α-889 is higher in MM patients than in controls. Similarly, Ziakas et al, (2013) (50) show that the G allele of IL-1β-1464G>C was significantly associated with MM in an Asian population. Of course, the discrepancies between the mentioned studies may also be due to small sample size and ethnic differences.…”
Section: Discussionmentioning
confidence: 94%